Xinshu Ding Quasi-blood glucose test system - Taiwan Registration cea87959acbe14b10bb779a7b86a88c3
Access comprehensive regulatory information for Xinshu Ding Quasi-blood glucose test system in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number cea87959acbe14b10bb779a7b86a88c3 and manufactured by APEX BIOTECHNOLOGY CORPORATION. The authorized representative in Taiwan is APEX BIOTECHNOLOGY CORPORATION.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Product Details
This product is an in vitro diagnostic medical device, which is used to quantitatively detect the blood glucose value of microvascular whole blood, venous whole blood and arterial whole blood collected from fingertips, palms and forearms, and is also suitable for neonatal microvascular whole blood. It is available for diabetic patients to use at home and for professionals.
A Clinical chemistry and clinical toxicology
A.1345 Glucose Test System
ๅ็ข;; QMS/QSD
Dates and Status
Jun 06, 2023
Jun 06, 2028